I think you are right to focus on the forecasts given. However, I know Wayne will view the forecast as an annual target and will not be too phased by how close this quarter is. What will matter to him is what the Adapt number is for the end of the year.
We have had some regulatory delays that will impact (delay) Adapt sales and possibly the forecasts.
It’s the annual number that matters, the quarters may turn out a bit different in the way they piece together the result.
On the other hand, who knows we may well hit this quarters targets. Especially if we have made sales to 4C Medical for their human trials.
Almost 2 years ago there was a Trading Halt and CR (29/07/2016), page-108
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |